Search Results - "Bartoni, Kathy"
-
1
Randomized Comparison of Sulbactam/Cefoperazone with Imipenem as Empirical Monotherapy for Febrile Granulocytopenic Patients
Published in Clinical infectious diseases (01-03-1998)“…In a prospective, randomized, controlled trial, we compared sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile, granulocytopenic…”
Get full text
Journal Article -
2
Randomized Comparison of Oral Valacyclovir and Intravenous Ganciclovir for Prevention of Cytomegalovirus Disease after Allogeneic Bone Marrow Transplantation
Published in Clinical infectious diseases (15-03-2003)“…In this multicenter, randomized study, cytomegalovirus (CMV)-seropositive patients who received an allogeneic bone marrow transplant were provided high-dose…”
Get full text
Journal Article -
3
Efficacy, Safety, and Breakthrough Infections Associated with Standard Long-Term Posaconazole Antifungal Prophylaxis in Allogeneic Stem Cell Transplantation Recipients
Published in Biology of blood and marrow transplantation (01-04-2011)“…Based on favorable results from randomized clinical trials, oral posaconazole has been approved for prophylaxis in neutropenic patients and stem cell…”
Get full text
Journal Article -
4
Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients : results of a placebo-controlled, double-blind trial
Published in Annals of internal medicine (01-02-1993)“…To evaluate the efficacy and safety of ganciclovir for prevention of cytomegalovirus (CMV) infection and disease. A randomized, placebo-controlled,…”
Get full text
Journal Article -
5
Elimination ofAspergillusinfection in allogeneic stem cell transplant recipients with long-term itraconazole prophylaxis: prevention is better than treatment
Published in Blood (01-09-2004)Get full text
Journal Article -
6
-
7
Ganciclovir Therapy for Cytomegalovirus Infections in Recipients of Bone Marrow Transplants and Other Immunosuppressed Patients
Published in Reviews of infectious diseases (01-07-1988)“…The efficacy and safety of ganciclovir were evaluated for the treatment of 39 life-threatening or sight-threatening cytomegalovirus (CMV) infections in…”
Get full text
Journal Article